Vivos Therapeutics, Inc. (VVOS)

Vivos Therapeutics Revenue

Vivos Therapeutics had revenue of $6.78M in the quarter ending September 30, 2025, with 75.73% growth. This brings the company's revenue in the last twelve months to $17.32M, up 18.76% year-over-year. In the year 2024, Vivos Therapeutics had annual revenue of $15.03M with 8.91% growth.

• Revenue (ttm): $17.32M
• Revenue Growth: +18.76%
• P/S Ratio: 0.82
• Revenue / Employee: $66,095
• Employees: 262
• Market Cap: 14.13M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	15.03M	1.23M	8.91%
Dec 31, 2023	13.80M	-2.22M	-13.87%
Dec 31, 2022	16.02M	-861.00K	-5.10%
Dec 31, 2021	16.89M	3.82M	29.23%
Dec 31, 2020	13.07M	1.67M	14.68%
Dec 31, 2019	11.39M	7.60M	200.43%
Dec 31, 2018	3.79M	-	-